File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/00005344-199512000-00011
- Scopus: eid_2-s2.0-0028856028
- PMID: 8606529
- WOS: WOS:A1995TJ43500011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Activation of protein kinase C as a modulator of potentiated UK-14304-induced contraction in dog mesentene artery and vein
Title | Activation of protein kinase C as a modulator of potentiated UK-14304-induced contraction in dog mesentene artery and vein |
---|---|
Authors | |
Keywords | Amplification Calphostin C Protein kinase C α-Adrenoceptors |
Issue Date | 1995 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ |
Citation | Journal of Cardiovascular Pharmacology, 1995, v. 26 n. 6, p. 923-931 How to Cite? |
Abstract | We assessed the role of protein kinase C (PKC) in the mechanism responsible for the potentiation of UK-14304-induced contractions produced when isolated dog mesenteric vascular rings were pretreated with threshold concentrations of 12-O-tetradecanoyl-phorbol-13-acetate (TPA), KCl, or endothelin-1 (ET-1). In dog mesenteric artery. UK-14304 produced a biphasic concentration-response curve in the presence of TPA, KCl, or ET-1, with the curve portion at lower concentrations being alpha 2-adrenoceptor dependent and the portion at higher concentrations being alpha 1-adrenoceptor dependent. Calphostin C (10(-6)M), a PKC inhibitor, abolished amplified UK-14304-induced contraction in the TPA-pretreated tissues. In the KCl- and ET-1-pretreated tissues. 10(-6)M calphostin C antagonized amplified UK-14304-induced contractions by approximately 20% in both parts of the concentration-response curve. In contrast, in dog mesenteric vein, amplified UK-14304-induced contractions by TPA, KCl, and ET-1 were entirely dependent on alpha 2-adrenoceptors. Calphostin C (10(-6)M), which in control experiments had no effect on KCl-induced contraction and antagonized responses to TPA by 60.1%, inhibited UK-14304-induced contraction by 18.3%. Amplified UK-14304-induced contraction was antagonized by 10(-6)M calphostin C by 21.8% in KCl-precontracted tissues, 58.1% in ET-1-precontracted tissues, and 66.3% in TPA-precontracted tissues. In the ET-1- and TPA-pretreated dog mesenteric veins, 10(-6)M calphostin C decreased maximal tensions of enhanced UK-14304-induced contractions to the same level as the UK-14304-induced maximal tension inhibited by 10(-6)M calphostin C in untreated dog mesenteric vein. Therefore, TPA can be a precontracting agent that amplifies UK-14304-induced contractions through PKC activation in both dog mesenteric artery and vein. PKC predominantly mediates the contraction amplification mechanisms after exposure to ET-1 in dog mesenteric vein and does not play a major role in the amplification of UK-14304-induced contraction by KCl in both dog mesenteric artery and vein. These data show that a common mechanism need not underlie amplification of adrenergic responses in mesenteric artery and vein. |
Persistent Identifier | http://hdl.handle.net/10722/225143 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.610 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shimamoto, H | - |
dc.contributor.author | Shimamoto, Y | - |
dc.contributor.author | Kwan, DCY | - |
dc.contributor.author | Daniel, EE | - |
dc.date.accessioned | 2016-04-22T07:07:18Z | - |
dc.date.available | 2016-04-22T07:07:18Z | - |
dc.date.issued | 1995 | - |
dc.identifier.citation | Journal of Cardiovascular Pharmacology, 1995, v. 26 n. 6, p. 923-931 | - |
dc.identifier.issn | 0160-2446 | - |
dc.identifier.uri | http://hdl.handle.net/10722/225143 | - |
dc.description.abstract | We assessed the role of protein kinase C (PKC) in the mechanism responsible for the potentiation of UK-14304-induced contractions produced when isolated dog mesenteric vascular rings were pretreated with threshold concentrations of 12-O-tetradecanoyl-phorbol-13-acetate (TPA), KCl, or endothelin-1 (ET-1). In dog mesenteric artery. UK-14304 produced a biphasic concentration-response curve in the presence of TPA, KCl, or ET-1, with the curve portion at lower concentrations being alpha 2-adrenoceptor dependent and the portion at higher concentrations being alpha 1-adrenoceptor dependent. Calphostin C (10(-6)M), a PKC inhibitor, abolished amplified UK-14304-induced contraction in the TPA-pretreated tissues. In the KCl- and ET-1-pretreated tissues. 10(-6)M calphostin C antagonized amplified UK-14304-induced contractions by approximately 20% in both parts of the concentration-response curve. In contrast, in dog mesenteric vein, amplified UK-14304-induced contractions by TPA, KCl, and ET-1 were entirely dependent on alpha 2-adrenoceptors. Calphostin C (10(-6)M), which in control experiments had no effect on KCl-induced contraction and antagonized responses to TPA by 60.1%, inhibited UK-14304-induced contraction by 18.3%. Amplified UK-14304-induced contraction was antagonized by 10(-6)M calphostin C by 21.8% in KCl-precontracted tissues, 58.1% in ET-1-precontracted tissues, and 66.3% in TPA-precontracted tissues. In the ET-1- and TPA-pretreated dog mesenteric veins, 10(-6)M calphostin C decreased maximal tensions of enhanced UK-14304-induced contractions to the same level as the UK-14304-induced maximal tension inhibited by 10(-6)M calphostin C in untreated dog mesenteric vein. Therefore, TPA can be a precontracting agent that amplifies UK-14304-induced contractions through PKC activation in both dog mesenteric artery and vein. PKC predominantly mediates the contraction amplification mechanisms after exposure to ET-1 in dog mesenteric vein and does not play a major role in the amplification of UK-14304-induced contraction by KCl in both dog mesenteric artery and vein. These data show that a common mechanism need not underlie amplification of adrenergic responses in mesenteric artery and vein. | - |
dc.language | eng | - |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ | - |
dc.relation.ispartof | Journal of Cardiovascular Pharmacology | - |
dc.rights | This is a non-final version of an article published in final form in (provide complete journal citation) | - |
dc.subject | Amplification | - |
dc.subject | Calphostin C | - |
dc.subject | Protein kinase C | - |
dc.subject | α-Adrenoceptors | - |
dc.subject.mesh | Adrenergic alpha-Agonists - pharmacology | - |
dc.subject.mesh | Mesenteric Arteries - drug effects - physiology | - |
dc.subject.mesh | Protein Kinase C - physiology | - |
dc.subject.mesh | Quinoxalines - pharmacology | - |
dc.subject.mesh | Vasoconstriction - drug effects | - |
dc.title | Activation of protein kinase C as a modulator of potentiated UK-14304-induced contraction in dog mesentene artery and vein | - |
dc.type | Article | - |
dc.identifier.email | Kwan, DCY: cykwan@hkucc.hku.hk | - |
dc.identifier.doi | 10.1097/00005344-199512000-00011 | - |
dc.identifier.pmid | 8606529 | - |
dc.identifier.scopus | eid_2-s2.0-0028856028 | - |
dc.identifier.hkuros | 11234 | - |
dc.identifier.volume | 26 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 923 | - |
dc.identifier.epage | 931 | - |
dc.identifier.isi | WOS:A1995TJ43500011 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0160-2446 | - |